Metabolic Screening After the American Diabetes Association's Consensus Statement on Antipsychotic Drugs and Diabetes

OBJECTIVE: Several second-generation antipsychotic (SGA) drugs have been associated with weight gain, hyperglycemia, and dyslipidemia. We evaluated whether glucose and lipid testing increased after the American Diabetes Association (ADA) consensus statement recommending metabolic monitoring for SGA-...

Descripción completa

Detalles Bibliográficos
Autores principales: Morrato, Elaine H., Newcomer, John W., Kamat, Siddhesh, Baser, Onur, Harnett, James, Cuffel, Brian
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2681020/
https://www.ncbi.nlm.nih.gov/pubmed/19244091
http://dx.doi.org/10.2337/dc08-1720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2681020/
https://www.ncbi.nlm.nih.gov/pubmed/19244091
http://dx.doi.org/10.2337/dc08-1720

Ejemplares similares